Using HLA-DRB1*04:01:citrullinated-peptide tetramers, CD4+ T cells reactive with citrulline-modified peptides derived from vimentin, aggrecan, and other proteins have been identified in the blood of ACPA+ RA patients11–15,22. The gene discussed is VIM; the disease is rheumatoid arthritis.